Kimberly-Clark announced it will acquire Kenvue in a cash and stock transaction valued at $48.7 billion.
The deal brings together two iconic companies that will combine their portfolios of complementary products, including 10 billion-dollar brands, that touch nearly half the global population.
Based on current projections, the combined company would generate 2025 annual net revenues of approximately $32 billion and approximately $7 billion of adjusted EBITDA.
Kenvue, a Johnson & Johnson spinoff, is the world’s largest pure-play consumer health company, with brands including Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena and Tylenol.
Kimberly-Clark’s brands include Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, Goodnites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll hold No. 2 share positions in approximately 70 countries.
Author summary: Kimberly-Clark acquires Kenvue for $48.7 billion.